Is a complete LON/0JQ2 research report available?

Question

Accepted Answer

No complete published report is available for lon/0JQ2 (LON/0JQ2) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	7.3M
Net income (ttm)	-7.6M
EPS (ttm)	-$0.98
Volume	3,095
Beta	-2.28

Metric	Value
Country	United States
Country code	UK
Employees	6
Employees Change	-5%
Employees Change Percent	-11.63
Enterprise value	$1.9M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US4831193010
Last refreshed	2026-09-09
Market cap	$7.3M
Price	$0.53
Price currency	USD
Sector	Healthcare
Sector PE	21.55
Sector PE Fwd	13.76
Sic	2836
Symbol	lon/0JQ2
Website	https://www.kalarx.com

Metric	Value
Earnings Yield	-104.7%
FCF yield	-206.48%
P/B ratio	1.06x

Metric	Value
Net Income	$-7.6M
Net Income Growth Quarters	4%
Net Income Growth Years	4%
Profit Per Employee	$-1.3M
ROA	-65.43
Roa5y	-48.81
ROCE	-269.9
ROE	-345.3
Roe5y	-296.2
ROIC	-85.3

Metric	Value
Cagr1y	-99.93%
Cagr3y	-90.99%
Cagr5y	-85.64%
EPS Growth Quarters	11
EPS Growth Years	4
Revenue Growth Years	0x

LON/0JQ2 (LON/0JQ2)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0JQ2

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0JQ2 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0JQ2

Frequently asked questions

Metric	Value
Assets	$8M
Cash	$5.4M
Current Assets	$7.8M
Current Liabilities	$1.1M
Debt	$0
Equity	$6.8M
Interest Coverage	-22.11
Liabilities	$1.2M
Long Term Assets	$161,153
Long Term Liabilities	$23,423
Net Cash	$5.4M
Net Cash By Market Cap	$75.09
Net Cash Growth	259.29%
Net Debt Equity	$-0.8
Tangible Book Value	$6.8M
Tangible Book Value Per Share	$0.35
WACC	-8.3

Metric	Value
Current ratio	6.88
Net Working Capital	$1.4M
Quick ratio	4.84
Working Capital	$6.8M

Metric	Value
1Y total return	-99.93%
200-day SMA	13.94
3Y total return	-99.93%
50-day SMA	0.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.99%
All Time High	45,250
All Time High Change	-100%
All Time High Date	2018-03-19
All Time Low	0.5
All Time Low Change	0%
All Time Low Date	2026-09-08
ATR	0.13
Beta	-2.28
Ch YTD	-98.18
High	0.53
High52	1,028.6
High52 Date	2025-09-17
High52ch	-99.95%
Low	0.5
Low52	0.5
Low52 Date	2026-09-08
Low52ch	5.04%
Ma50ch	-45.48%
Price vs 200-day SMA	-96.41%
RSI	25.66
RSI Monthly	32.88
RSI Weekly	33.26
Sharpe ratio	-2.57x
Sharpe Ratio3y	-0.84x
Sortino ratio	-3.13
Sortino Ratio3y	-1.23
Total Return	-6,874.92%
Tr YTD	-98.18
Tr1m	-29.85%
Tr1w	-25.61%
Tr3m	-76.42%

Metric	Value
Float	19,338,758%
Net Borrowing	-14,730,281
Shares Insiders	0.01%
Shares Institutions	3.61%
Shares Qo Q	-99.38%
Shares Yo Y	6,874.92%
Short Ratio	0.77

Metric	Value
Adjusted FCF	$-17.9M
Adjusted OCF	-17,921,479
Average Volume	13,331.85x
Bv Per Share	0.35
CAPEX	$-11,306
Ch1m	-29.85
Ch1w	-25.61
Ch1y	-99.93
Ch3m	-76.42
Ch3y	-99.93
Ch5y	-99.99
Ch6m	-96.43
Change	3.39%
Change From Open	0.79
Close	0.51
Days Gap	2.58
Depreciation Amortization	251,449.4
Dollar Volume	1,625.5
Earnings Date	2026-11-19
EBIT	$-18.4M
EBITDA	$-18.1M
EPS	$-0.98
F Score	1
FCF	$-15M
FCF EV Yield	-784.54x
Financing CF	-3,656,199
Fiscal Year End	December
Founded	2,009
Investing CF	-5,275,146
Is Primary Listing	0
Last Earnings Date	2025-11-07
Last Report Date	2026-06-30
Last Split Date	2026-05-11
Last Split Type	Reverse
Ma150	6.94
Ma150ch	-92.79%
Ma20	0.76
Ma20ch	-34.03%
Net CF	-23,902,088
Next Earnings Date	2026-11-19
Open	0.52
Position In Range	100
Price Date	2026-09-08
Ptbv Ratio	1.06
Relative Volume	0.23x
Share Based Comp	2,950,736
Tr6m	-96.43%
Volume	3,095